Dr. Charles Douglas Rice Jr., MD

Dr. Rice practices at Hendricks Regional Health Danville Hospital in Danville, Indiana, part of Hendricks Regional Health.

Dr. Rice's NPI, 1558522763, was assigned on June 19, 2008. Dr. Rice holds Indiana license 01077160A.

Dr. Rice's primary practice is Hendricks Regional Health Danville Hospital, at 1000 E Main St, Danville, IN 46122 in Hendricks County. The practice phone is (317) 745-4451.

Dr. Rice's primary practice is Hendricks Regional Health Danville Hospital in Danville, Indiana, part of Hendricks Regional Health. Dr. Rice is also affiliated with Charleston Area Medical Center General Hospital. The medical group on file is Hendricks Rheumatology. Dmand AI also links Dr. Rice to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rice practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Rice's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Rice's licenses on file in 2 states: Indiana and North Carolina.

CMS data shows 450 Medicare services from Dr. Rice across 7 procedure codes in 2024, for 150 Medicare patients. Medicare paid $33,140 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 150 Medicare patients who saw Dr. Rice in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rice's median patient age at 70, with 52% women.

In 2024, Dr. Rice wrote 29 Medicare Part D claims for 19 patients. 93% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $204 in total drug cost. In 2023, CMS named 87 claims across 3 drugs.

Dr. Rice accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 50 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Rice, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 28 papers to Dr. Rice, published from 2011 to 2023. 2017 was the busiest year, with 3. The most frequent topics are Water Pollutants, Chemical, Fundulidae and Bottle-Nosed Dolphin. Dr. Rice has published most often in Environ Toxicol Chem.

CMS Open Payments shows 34 general payments to Dr. Rice from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Celgene Corporation paid the most, $215.